Pyramax®, a fixed-dose combination of pyronaridine and artesunate, becomes the first antimalarial to be granted a positive scientific opinion from the European Medicines Agency (EMA) under Article 58.

The World Health Organisation prequalified and Ghana Food and Drugs Authority registered Antimalarial Pyramax (Artesunate-Pyronaridine), a fixed-dose combination medication for the treatment of ...

Dovizia Pharma Services has laun-ched Pyra-max, a malaria drug into the market. Speaking at the unvei-ling of the drug in Lagos, Chairman of the occasion, Professor Akin Osinbogun said that about $35 ...

MMV (http://www.MMV.org) and Shin Poong Pharm. Co., Ltd. welcome the formal inclusion of Pyramax ® (pyronaridine-artesunate) in the World Health Organization’s ...

Pyramax, an experimental once-a-day malaria drug developed by Korea's Shin Poong Pharmaceutical and the Medicines for Malaria Venture, works just as well as Novartis' twice-daily pill Coartem, ...

The fight against malaria has gone a notch higher after the introduction of a new anti - malaria drug in the market. The drug, known as Pyramax, is a fixed dose combination of two drugs that protects ...

Pyramax which was developed by Shin Poong Pharm, a Korean company, stays in the body for a long time thus protecting the patient for an extended period. Mr Bob Peter Okello, the country manager of ...

A Korean firm, Shin Poong Pharmaceutical Company, says it has produced an anti-malaria drug that will reduce the increasing number of malaria-induced ailments among Nigerians. The Chief Executive ...

The World Health Organisation prequalified and Ghana Food and Drugs Authority registered Antimalarial Pyramax (Artesunate-Pyronaridine), a fixed-dose combination medication for the treatment of ...

The World Health Organisation prequalified and Ghana Food and Drugs Authority registered Antimalarial Pyramax (Artesunate-Pyronaridine), a fixed-dose combination medication for the treatment of ...